These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9213373)

  • 1. Selectivity of [Phe-I7], [Ala6], and [D-Ala4,Gln5,Tyr6] substituted ACTH(4-10) analogues for the melanocortin receptors.
    Schiöth HB; Muceniece R; Wikberg JE
    Peptides; 1997; 18(5):761-3. PubMed ID: 9213373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
    Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
    Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
    Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
    Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH.
    Schiöth HB; Muceniece R; Larsson M; Wikberg JE
    J Endocrinol; 1997 Oct; 155(1):73-8. PubMed ID: 9390008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
    Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
    Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin peptides: antagonists of melanocortin receptors.
    Quillan JM; Sadée W
    Pharm Res; 1997 Jun; 14(6):713-9. PubMed ID: 9210186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
    Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
    Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors.
    Schiöth HB; Chhajlani V; Muceniece R; Klusa V; Wikberg JE
    Life Sci; 1996; 59(10):797-801. PubMed ID: 8761313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
    Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
    Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological comparison of rat and human melanocortin 3 and 4 receptors in vitro.
    Schiöth HB; Bouifrouri AA; Rudzish R; Muceniece R; Watanobe H; Wikberg JE; Larhammar D
    Regul Pept; 2002 Jun; 106(1-3):7-12. PubMed ID: 12047904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes.
    Schiöth HB; Müceniece R; Mutulis F; Prusis P; Lindeberg G; Sharma SD; Hruby VJ; Wikberg JE
    Peptides; 1997; 18(7):1009-13. PubMed ID: 9357059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanin-concentrating hormone, melanocortin receptors and regulation of luteinizing hormone release.
    Murray JF; Adan RA; Walker R; Baker BI; Thody AJ; Nijenhuis WA; Yukitake J; Wilson CA
    J Neuroendocrinol; 2000 Mar; 12(3):217-23. PubMed ID: 10718917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues.
    Schiöth HB; Tesfaye A; Mutulis F; Rudzish R; Mutule I; Muceniece R; Watanobe H; Wikberg JE
    Neuropeptides; 2002 Dec; 36(6):427-34. PubMed ID: 12507437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel melanocortin4 receptor selective MSH analogues.
    Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
    Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
    Oosterom J; Burbach JP; Gispen WH; Adan RA
    Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
    Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
    Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the ACTH, MSH, and neural (MC3 and MC4) melanocortin receptors in the mouse and human.
    Magenis RE; Smith L; Nadeau JH; Johnson KR; Mountjoy KG; Cone RD
    Mamm Genome; 1994 Aug; 5(8):503-8. PubMed ID: 7949735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the melanocortin 4 receptor by radioligand binding.
    Schiöth HB; Muceniece R; Wikberg JE
    Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.